Aurora Cannabis shares have a positive outlook
Aurora Cannabis Inc. got a license for selling medical cannabis in 2014. Currently, the company has got eight licensed production facilities in 18 countries producing over 500,000 kg of cannabis yearly. According to its market cap, Aurora Cannabis ranks second among the companies in this sector, the first being Canopy Growth Corp.
In 2018, the sale of cannabis for recreational purposes was legalized in Canada, with sales starting on 17 October. There has been an increased demand for this product among the Canadian population, and some regions of Canada are even experiencing a shortage of cannabis.
Currently, Aurora Cannabis Inc. intends to increase its cannabis production capacity. A new plant in Alberta, capable of producing 100,000 kg of cannabis per year, is being constructed in Alberta.
Since October 2018, the company's shares have been traded on the NYSE as ACB. The current price of Aurora Cannabis shares in New York is just a bit over $6. The stock price increased sharply soon after the IPO amid a surge of interest in this sector, which was largely driven by the start of recreational cannabis sales: at that time, the company's shares were worth almost $12. Then, the market hype calmed down; Aurora Cannabis fell first to $5.90, rising after this to $7-$8 temporarily, and finally stabilizing to just above $6 most recently.
The hype in the cannabis sector is likely over. That being said, a possible increase in production capacity could turn out promising.
Not financial advice. The content of this article is provided by Libertex for general information and educational purposes only. It does not constitute investment advice, investment research, a personal recommendation, or an offer or solicitation to buy or sell any financial instrument or other asset. It is general in nature and is not tailored to any individual reader, so it cannot account for your personal circumstances, financial situation, knowledge, experience, or investment objectives. Any decision to act on this content is taken at your own discretion and risk, and you remain solely responsible for assessing whether a product or strategy is right for you and for seeking independent professional advice where appropriate.
Risk warning. Trading in financial instruments and other assets, particularly leveraged products such as CFDs, is complex and carries a high risk of losing money rapidly. Leverage magnifies both gains and losses, so small market movements can lead to disproportionate losses. The value of the assets referenced may rise or fall, and you may lose your entire invested amount. Past performance is not a reliable indicator of future results. The use of artificial intelligence, algorithms, automated strategies, or any other analytical tool in trading does not guarantee any particular outcome, does not eliminate risk, and does not replace your own judgement — you remain fully responsible for assessing every instrument, strategy, and decision, and for the results of your trading.
Why trade with Libertex?
- Get access to a demo account free of charge
- Receive live technical assistance 5 days a week, 24 hours a day
- Enjoy leverage of up to 1:500
- Use a platform for any device: Libertex and MetaTrader 4 and 5
- Pay zero commission on withdrawals in Latin America
- Benefit from up to $500 protection on your first trades with Negative Trade Protection